ABBOTT LABORATORIES .

Abbott Labs stock gains 1.99% at $102.46, trading above its 200‑day SMA, with cyber‑security threats sparking a focus on secure device innovation.

Abbott Laboratories’ latest market snapshot shows a 1.89% dip, yet its solid fundamentals and disciplined capital strategy make the current price an attractive entry for value investors.

Abbott Laboratories stock dips 0.79% to $104.06 on Oct 21, 2026, trading above its 200‑day MA within a $81.97–$132.03 range and a $181.5 bn market cap.